Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Dopamine Test to Enable Early Detection of Neurological Disorders

By LabMedica International staff writers
Posted on 06 Sep 2024

Neurotransmitters are essential for regulating neural function and overall well-being in humans and animals, ensuring a balanced hormonal environment for optimal body functioning. More...

Dopamine is particularly critical, significantly influencing cognitive functions like motor skills and emotions such as happiness and pleasure. Apart from its role in regulating emotions, dopamine also acts as a biomarker for screening certain cancers and neurological disorders. Variations in dopamine levels are linked to a range of neurodegenerative diseases, including Parkinson’s and Alzheimer’s, as well as neurodevelopmental and psychological disorders like ADHD, Tourette’s Syndrome, bipolar disorder, and schizophrenia. Accurate measurement of dopamine levels is crucial for advancing both pharmaceutical research and clinical therapies. Now, a newly developed integrated optical sensor capable of detecting dopamine directly from unprocessed blood samples offers a cost-effective and efficient method for screening various neurological conditions and cancers, thus potentially enhancing patient outcomes.

The plasmonic sensor developed at University of Central Florida (Orlando, FL, USA) utilizes a small gold pattern that causes electrons to oscillate collectively in what are known as plasmons, intensified by a specific optical setup. The introduction of a molecule to the sensor's environment alters electron movement, modifying the light reflection off the sensor and facilitating molecule detection. In contrast to traditional biosensors that depend on biological components such as antibodies or enzymes, this novel sensor employs a specially crafted aptamer, a synthetic DNA strand, that targets dopamine specifically. This design not only reduces costs and extends the shelf life of the sensor but also allows for the direct detection of dopamine in unprocessed blood, eliminating the need for sample preparation. This innovation is particularly valuable in resource-limited settings, simplifying the diagnostic process and potentially allowing for the detection of other conditions using similar technology.

The researchers optimized molecule detection by applying an aptamer to the sensor's active area, designed to bind precisely to targeted biomarkers. The findings published in Science Advances, demonstrate the sensor's ability to rapidly and accurately diagnose diseases. This advancement builds on previous work where the team enhanced the sensor’s selectivity and broadened its clinical applications by substituting cerium oxide nanoparticles with DNA-based aptamers, thus enabling the direct detection of dopamine in various biological samples without the need for prior sample preparation.

“This plasmonic biosensor is extremely sensitive to low concentrations of biomolecules, which make them promising platform for specialized assays, point of care applications in remote locations,” said UCF NanoScience Technology Center Professor Debashis Chanda, the study’s principal investigator. “In this work, we demonstrated an all-optical, surface-functionalized plasmonic biosensing platform for the detection of low concentrations of neurotransmitter dopamine directly from diverse biological samples which includes protein solutions, artificial cerebrospinal fluid, and unprocessed whole blood.”

Related Links:
University of Central Florida


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.